Aquatic Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Aquatic Capital Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$986K	Buy	+17,231	New	+$944K	0.03%	563
2025 Q4	–	Sell	-11,807	Closed	-$639K	–	1421
2025 Q3	$639K	Buy	+11,807	New	+$675K	0.01%	807
2024 Q4	–	Sell	-198,000	Closed	-$13.9M	–	1345
2024 Q3	$13.9M	Buy	+198,000	New	+$16.6M	0.36%	77
2024 Q2	–	Sell	-16,000	Closed	-$1.4M	–	1247
2024 Q1	$1.4M	Sell	16,000 -26,500	-62%	-$2.37M	0.05%	326
2023 Q4	$4.1M	Buy	+42,500	New	+$3.76M	0.1%	197
2023 Q3	–	Sell	-6,100	Closed	-$529K	–	1264
2023 Q2	$529K	Sell	6,100 -32,100	-84%	-$3.02M	0.03%	438
2023 Q1	$3.71M	Buy	+38,200	New	+$3.96M	0.23%	116
2022 Q4	–	Sell	-21,600	Closed	-$1.83M	–	1378
2022 Q3	$1.83M	Buy	+21,600	New	+$1.92M	0.18%	161
2022 Q2	–	Sell	-700	Closed	-$54K	–	1213
2022 Q1	$54K	Buy	+700	New	+$58.6K	0.08%	268

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Aquatic Capital Management's BMRN Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2026: 17,231 shares worth $986K. The stake represents 0.03% of the portfolio and ranks #563 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in BMRN as recently as Q3 2025.

Aquatic Capital Management first reported a position in BMRN in Q1 2022 and has held it in 9 quarters since. The position peaked at $13.9M in Q3 2024. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Aquatic Capital Management held 17,231 shares of BioMarin Pharmaceuticals worth $986K as of Q2 2026.
BioMarin Pharmaceuticals was a new Aquatic Capital Management position in Q2 2026.
BioMarin Pharmaceuticals made up 0.03% of Aquatic Capital Management's portfolio in Q2 2026, its #563 holding.
Aquatic Capital Management first reported a position in BioMarin Pharmaceuticals in Q1 2022 and has held it in 9 quarters since.
Aquatic Capital Management's BioMarin Pharmaceuticals position peaked at $13.9M in Q3 2024.
565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.